Satellite Bio
Unlocking the full potential of liver cells as medicine
- Headquarters
- Cambridge, Massachusetts
- Employees
- 11–50
- Founded
- 2019
- Business Model
- B2B
- Website
- satellite.bio
- Total Funding
- $101.5M
- Last Round
- $19.0M SeedApr 2022
About
Satellite Bio is a Cambridge, Massachusetts-based biotech company pioneering tissue therapeutics. Its proprietary off-the-shelf liver therapy delivers functional hepatocytes into the body to engraft and restore liver function. The company raised $110M across seed and Series A rounds and emerged from stealth in 2022. It uses drug-like manufacturing for scalable, cost-effective global distribution.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account